Topic

Cancer

Latest breakthroughs in cancer research, treatment, and prevention

643 articles

Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy
Cancer Research

Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy

Italian researchers track genomic and cellular changes in myeloma patients to uncover why anti-CD38 treatments stop working.

Clinical Trial
Jun 16, 2026 0
Phase II Trial Pits Dual Checkpoint Blockade Against Ipilimumab Alone in Advanced Melanoma
Cancer Research

Phase II Trial Pits Dual Checkpoint Blockade Against Ipilimumab Alone in Advanced Melanoma

NCI-sponsored trial tests whether adding nivolumab to ipilimumab improves outcomes in stage III/IV unresectable melanoma.

Clinical Trial
Jun 16, 2026 0
Host Immune Cells Determine Who Responds to CAR T Cell Therapy in Brain Cancer
Cancer Research

Host Immune Cells Determine Who Responds to CAR T Cell Therapy in Brain Cancer

A landmark Cell study reveals that the patient's own immune system—not just CAR T cells—decides outcomes in recurrent glioblastoma.

Research Paper
Jun 16, 2026 0
Multi-Omics Integration Is Reshaping How We Understand and Treat AML
Cancer Research

Multi-Omics Integration Is Reshaping How We Understand and Treat AML

A comprehensive review reveals how combining genomics, proteomics, and metabolomics is uncovering new AML targets and improving patient outcomes.

Research Paper
Jun 15, 2026 0
How Aging's Inflammatory Clock Fuels Colorectal Cancer Risk
Cancer Research

How Aging's Inflammatory Clock Fuels Colorectal Cancer Risk

A major review reveals how inflammaging and immunosenescence synergistically drive colorectal cancer in older adults, reshaping the tumor microenvironment.

Research Paper
Jun 15, 2026 0
Talquetamab Shows 60% Response Rate in Japanese Myeloma Patients with No Dose-Limiting Toxicity
Cancer Research

Talquetamab Shows 60% Response Rate in Japanese Myeloma Patients with No Dose-Limiting Toxicity

Phase 1 data from 15 heavily pretreated Japanese myeloma patients confirms talquetamab's safety and efficacy, matching global trial results.

Research Paper
Jun 15, 2026 0
AI-Guided Cancer Care Program Targets Immunotherapy Gaps in Minority NSCLC Patients
Cancer Research

AI-Guided Cancer Care Program Targets Immunotherapy Gaps in Minority NSCLC Patients

A Columbia University trial tested a digital care service to improve immunotherapy outcomes and reduce healthcare burden for minority lung cancer patients.

Clinical Trial
Jun 15, 2026 0
Peter Attia's Complete Guide to Personalizing Your Breast Cancer Screening Strategy
Cancer Research

Peter Attia's Complete Guide to Personalizing Your Breast Cancer Screening Strategy

Peter Attia breaks down why standard screening guidelines fall short and how to build a personalized, risk-based breast cancer detection plan.

Podcast
Jun 15, 2026 0
CAR-T and CAR-NK Cells Are Rewriting the Treatment Playbook for Deadly AML
Cancer Research

CAR-T and CAR-NK Cells Are Rewriting the Treatment Playbook for Deadly AML

A sweeping review of CAR-T and CAR-NK cell therapies in acute myeloid leukemia, covering clinical trial outcomes, key targets, and next-gen strategies.

Research Paper
Jun 14, 2026 0
MOBIDERM Compression Panty Tested for Pelvic and Genital Lymphedema Relief
Cancer Research

MOBIDERM Compression Panty Tested for Pelvic and Genital Lymphedema Relief

A completed exploratory trial evaluates whether a specialized compression garment can reduce discomfort and improve quality of life in pelvic lymphedema patients.

Clinical Trial
Jun 14, 2026 0
Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond
Cancer Research

Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond

A randomized Phase 2 trial investigates whether PD-1 inhibitor discontinuation after early response is safe in non-small cell lung cancer.

Clinical Trial
Jun 14, 2026 0
Blue Light Surgery Cuts Bladder Cancer Recurrence by Up to 32% in High-Risk Patients
Cancer Research

Blue Light Surgery Cuts Bladder Cancer Recurrence by Up to 32% in High-Risk Patients

A Cochrane meta-analysis of 17 RCTs finds blue light TURBT reduces bladder cancer recurrence and progression, especially in intermediate- and high-risk patients.

Review
Jun 13, 2026 0
PreviousPage 6 of 54Next